AIP
IRON icon

Ameritas Investment Partners’s Disc Medicine IRON Stock Holding History

Ameritas Investment Partners’s Portfolio IRON Stock Details IRON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$188K Buy
2,568
+320
+14% +$22K 0.01% 1432
2026
Q1 		$144K Buy
2,248
+189
+9% +$13.1K ﹤0.01% 1463
2025
Q4 		$164K Buy
2,059
+128
+7% +$10.8K 0.01% 1377
2025
Q3 		$128K Sell
1,931
-584
-23% -$34.7K ﹤0.01% 1527
2025
Q2 		$133K Buy
2,515
+206
+9% +$9.68K ﹤0.01% 1559
2025
Q1 		$115K Buy
2,309
+310
+16% +$17.2K ﹤0.01% 1608
2024
Q4 		$127K Hold
1,999
– – ﹤0.01% 1623
2024
Q3 		$98.2K Buy
1,999
+389
+24% +$18.3K ﹤0.01% 1804
2024
Q2 		$72.6K Buy
1,610
+725
+82% +$24.6K ﹤0.01% 1933
2024
Q1 		$55.1K Hold
885
– – ﹤0.01% 2091
2023
Q4 		$51.1K Hold
885
– – ﹤0.01% 2162
2023
Q3 		$41.6K Buy
885
+246
+38% +$12.3K ﹤0.01% 2203
2023
Q2 		$28.4K Buy
+639
New +$22.7K ﹤0.01% 2363
2022
Q2 		– Sell
-57
Closed -$2K – 3151
2022
Q1 		$2K Hold
57
– – ﹤0.01% 3047
2021
Q4 		$5K Hold
57
– – ﹤0.01% 3040
2021
Q3 		$7K Hold
57
– – ﹤0.01% 3003
2021
Q2 		$11K Buy
+57
New +$18.7K ﹤0.01% 2914

Other funds holding IRON

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $881M AUM 160.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Ameritas Investment Partners's IRON Position: Q2 2026 in Review

Ameritas Investment Partners increased its Disc Medicine (IRON) stake by 14% in Q2 2026, buying an estimated $22K and bringing the position to 2,568 shares worth $188K. The position accounts for 0.01% of the portfolio, ranked #1432.

Ameritas Investment Partners first reported a position in IRON in Q2 2021 and has held it in 17 quarters since. 215 funds tracked by Wall St. Rank hold IRON as of Q2 2026.

  • Ameritas Investment Partners held 2,568 shares of Disc Medicine worth $188K as of Q2 2026.
  • Ameritas Investment Partners bought 320 Disc Medicine shares in Q2 2026, an estimated $22K.
  • Disc Medicine made up 0.01% of Ameritas Investment Partners's portfolio in Q2 2026, its #1432 holding.
  • Ameritas Investment Partners first reported a position in Disc Medicine in Q2 2021 and has held it in 17 quarters since.
  • 215 funds tracked by Wall St. Rank held Disc Medicine as of Q2 2026.

Based on Ameritas Investment Partners's 13F filing for Q2 2026, filed 13 Aug 2026.